On Tuesday, February 4th, at 11am CST (9am PST/10am MST/12pm EST) Biogen and Cure SMA will co-host a webinar for the SMA community. During the webinar, you’ll hear from Biogen about the latest information on its SPINRAZA clinical trial, DEVOTE, a Phase 2/3 randomized, controlled dose-escalating study with infantile and later-onset SMA of all ages, including adults.
The 60-minute webinar will also include a Q&A session based on questions submitted in advance of the call. We encourage you to submit your questions when you register or by emailing [email protected], so that we can plan to answer as many of them as possible. We look forward to you joining us!
Please note that this webinar is intended for U.S. audiences only.
For more information about Spinraza, visit www.curesma.org/Spinraza.